Literature DB >> 15632690

Highly selective inhibition of inducible nitric oxide synthase ameliorates experimental acute pancreatitis.

Per Sandstrom1, Mark E Brooke-Smith, Anthony C Thomas, Marlene B Grivell, Gino T P Saccone, James Toouli, Joar Svanvik.   

Abstract

OBJECTIVES: Inducible nitric oxide synthase (iNOS) activity is increased in experimental acute pancreatitis. The aim of this study was to evaluate treatment with the selective iNOS inhibitors AR-C (AR-C102222AA) and L-NIL (L-N6-(1-iminoethyl)-lysine) in experimental acute pancreatitis.
METHODS: Acute pancreatitis was induced in anesthetized Australian possums by topical administration of carbachol on the sphincter of Oddi. AR-C treatment was 2 intravenous infusions (2.5 micromol/kg over 15 minutes) at 2 and 4 hours after acute pancreatitis induction. L-NIL treatment was an intraarterial infusion (1 mg/kg/h) from 2 hours after acute pancreatitis induction. At 8 hours, pancreatic tissue was harvested and inflammation assessed (histologic score). Blood samples were collected for plasma amylase, lipase, and amino acid levels. Blood pressure, central venous pressure, supplementary fluids, and urine output were monitored.
RESULTS: Treatment with AR-C or L-NIL reduced the plasma levels of amylase and the volume of supplementary fluids and improved the histological score (all P < 0.05). In animals with acute pancreatitis, plasma arginine levels were reduced (P < 0.05), while citrulline and ornithine levels increased (P < 0.05), consistent with increased nitric oxide production. Treatment with AR-C ameliorated the reduced arginine level.
CONCLUSIONS: Treatment with AR-C or L-NIL, commencing 2 hours after the induction of acute pancreatitis, has significant and beneficial effects in experimental acute pancreatitis in Australian possums.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15632690

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  5 in total

Review 1.  Free radicals and the pancreatic acinar cells: role in physiology and pathology.

Authors:  M Chvanov; O H Petersen; A Tepikin
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2005-12-29       Impact factor: 6.237

Review 2.  Pharmacologic therapy for acute pancreatitis.

Authors:  Swetha Kambhampati; Walter Park; Aida Habtezion
Journal:  World J Gastroenterol       Date:  2014-12-07       Impact factor: 5.742

Review 3.  Redox signaling in acute pancreatitis.

Authors:  Salvador Pérez; Javier Pereda; Luis Sabater; Juan Sastre
Journal:  Redox Biol       Date:  2015-01-28       Impact factor: 11.799

4.  Anchored plasticity opens doors for selective inhibitor design in nitric oxide synthase.

Authors:  Elsa D Garcin; Andrew S Arvai; Robin J Rosenfeld; Matt D Kroeger; Brian R Crane; Gunilla Andersson; Glen Andrews; Peter J Hamley; Philip R Mallinder; David J Nicholls; Stephen A St-Gallay; Alan C Tinker; Nigel P Gensmantel; Antonio Mete; David R Cheshire; Stephen Connolly; Dennis J Stuehr; Anders Aberg; Alan V Wallace; John A Tainer; Elizabeth D Getzoff
Journal:  Nat Chem Biol       Date:  2008-10-12       Impact factor: 15.040

5.  Nitric Oxide Synthase Inhibitors into the Clinic at Last.

Authors:  Vu Thao-Vi Dao; Mahmoud H Elbatreek; Thomas Fuchß; Ulrich Grädler; Harald H H W Schmidt; Ajay M Shah; Alan Wallace; Richard Knowles
Journal:  Handb Exp Pharmacol       Date:  2021
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.